Tag: Acetylcholinesterase Inhibitor

June 9, 2026 / Mohammed looti

Rivastigmine: Restoring Cognitive Function in Dementia

Rivastigmine: An Overview of its Therapeutic Role in Neurodegenerative Disorders Introduction: Unveiling Rivastigmine Rivastigmine is a pharmaceutical agent primarily utilized for the symptomatic treatment of mild to moderate stages of Alzheimer’s disease and mild to moderate Parkinson’s disease dementia. As an acetylcholinesterase inhibitor, its fundamental mechanism involves enhancing cholinergic neurotransmission within the brain. This enhancement […]

May 20, 2026 / Mohammed looti

PYRIDOSTIGMINE

Introduction to Pyridostigmine Pyridostigmine is a highly significant pharmacological agent primarily recognized for its critical role in the management of myasthenia gravis, a chronic, progressive autoimmune neuromuscular disorder characterized by fluctuating muscle weakness and pronounced fatigue. Structurally classified as a quaternary ammonium compound, pyridostigmine functions as an indirect-acting cholinergic agonist. This class of drugs plays […]